Advertisement
Advertisement

IMA

I

ImageneBio, Inc. Common Stock

5.29
USD
Sponsored
-0.62
-10.49%
May 08, 15:58 UTC -4
Closed
exchange

After-Market

5.54

+0.25
+4.73%

ImageneBio, Inc. Common Stock Profile

About

Inmagene Biopharmaceuticals is a clinical stage biotechnology company dedicated to developing disease-modifying treatments for immunological/autoimmune and inflammatory diseases. The company's lead asset includes IMG-007, a nondepleting anti-OX40 monoclonal antibody. Inmagene Biopharmaceuticals, formerly known as Ikena Oncology Inc., is based in SAN DIEGO.

Info & Links

CEO

Kristin Yarema

Headquarters

12526 HIGH BLUFF DRIVE SUITE 345
SAN DIEGO, CA 92130, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.inmagenebio.com

Auditor

PricewaterhouseCoopers LLP

Share holders

89

Employees

15

ImageneBio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

62.49M

Enterprise Value

-32.05M

Enterprise Value/EBITDA(ttm)

0.66

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.40

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-35.77%

Return on Invested Capital(ttm)

-34.29%

Return on Assets(ttm)

-31.78%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-48.29M

Net Income Available to Common(ttm)

-52.40M

Diluted EPS(ttm)

-8.07

Share Statistics

Beta (5Y Monthly)

0.55

52-Week Change

--

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

10.65M

Dividend Yield

0.00%

Float4

10.02M

% Held by Insiders

5.94%

% Held by Institutions

75.00%

Balance Sheet

Total Cash(mrq)

135.35M

Total Cash Per Share(mrq)

12.70

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

12.49%

Quick Ratio(mrq)

12.49%

Book Value Per Share(mrq)

11.91

Cash Flow

Operating Cash Flow Per Share(ytd)

-9.82

Free Cash Flow(ytd)

-47.84M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement